SCHEMBL7443125

SCHEMBL7443125

O=[N+]([O-])c1cccc(NS(=O)(=O)c2ccccc2Cl)c1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC25A1 P53007 1/20 0.68
▸ MEN1 O00255 4/20 0.60
▸ KMT2A Q03164 4/20 0.60
▸ NPC1 O15118 1/20 0.54
▸ IDH1 O75874 1/20 0.53
▸ SLC22A12 Q96S37 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ MAPT P10636 2/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ CRHBP P24387 1/20 0.48
▸ CRHR2 Q13324 1/20 0.48
▸ PGR P06401 2/20 0.48
▸ LMNA P02545 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10422318 0.82 SLC25A1 (0.66) SLC25A1MEN1KMT2ANPC1IDH1
SCHEMBL30252330 0.81 SLC25A1 (1.00) SLC25A1MEN1KMT2ANPC1POLB
SCHEMBL17329296 0.81 SLC25A1 (1.00) SLC25A1MEN1KMT2ANPC1POLB
SCHEMBL893934 0.80 CA2 (0.71) SLC25A1MEN1KMT2APOLBCA12
SCHEMBL16431026 0.78 PGR (0.64) SLC25A1MEN1KMT2APOLBCA2
SCHEMBL27579266 0.77 CA12 (0.51) SLC25A1MEN1KMT2AL3MBTL1CA12
SCHEMBL11137629 0.77 MEN1 (0.59) SLC25A1MEN1KMT2AIDH1POLB
SCHEMBL22980417 0.77 MCL1 (0.45) SLC25A1MEN1KMT2ANPC1SLC22A12
SCHEMBL3769126 0.77 PGR (0.73) MEN1KMT2ASLC22A12MAPTALDH1A1
SCHEMBL30737482 0.77 MEN1 (0.65) MEN1KMT2ASLC22A12POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0859607-B1 GUANIDINO PROTEASE INHIBITORS DIMENSIONAL PHARM INC (US) 2002-12-18 — — EP disclosed
EP-0859607-A4 GUANIDINO PROTEASE INHIBITORS DIMENSIONAL PHARM INC (US) 1999-05-06 — — EP disclosed
EP-0859607-A1 GUANIDINO PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-08-26 — — EP disclosed
US-5792769-A POTENT ANTICOAGULANT, ANTIINFLAMMATORY AGENT; TREATMENT/PROPHYLAXIS OF RESPIRATORY SYSTEM DISORDERS, VASCULAR SYSTEM DISORDERS, ANTITUMOR AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-08-11 — — US disclosed
WO-1997011693-A1 GUANIDINO PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1997-04-03 — — WO disclosed
Send feedback